Algerian study checks safety of common heart drug in daily practice
Knowledge-focused
Completed
This study observed 398 adults with atrial fibrillation in Algeria who were taking the blood thinner Trombix® (Rivaroxaban). Researchers tracked serious bleeding events and quality of life to see how the drug performs in real-world settings. The goal was to gather practical safet…
Sponsor: Beker Laboratories • Aim: Knowledge-focused
Last updated May 17, 2026 05:33 UTC